Bivalirudin Injection, Powder, Lyophilized, For Solution
Product Images NDC 16729-275

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bivalirudin (NDC 16729-275). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (Bivalirudin Carton Label)

Carton Label (Bivalirudin Carton Label)
The packaging label for Bivalirudin injection, 250 mg strength, lyophilized powder for solution, in a carton holding 10 single-dose vials. Labeled for intravenous use, single-dose only with Rx-only status. Marked with NDC 16729-275. The labeler is Accord Healthcare, Inc., with storage instructions and manufacturer details printed on the label followed by a barcode.*
FDA Label Image

Container Label (Bivalirudin Container Label)

Container Label (Bivalirudin Container Label)
Label for Bivalirudin for Injection 250 mg powder, lyophilized for solution by Accord Healthcare, Inc. The vial contains 250 mg of bivalirudin equivalent to 275 mg bivalirudin trifluoroacetate with excipients. It is for intravenous use only and single-dose. Storage conditions and manufacturer details are included along with a barcode and batch coding area.*
FDA Label Image

Bivalirudin Structure

Bivalirudin Structure
Chemical structure of bivalirudin, illustrating the detailed molecular arrangement of its peptide components and side chains as shown in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.